Predicting factors of fistula healing and clinical remission after infliximab-based combined therapy for perianal fistulizing Crohn's disease. [electronic resource]
Producer: 20090710Description: 1746-52 p. digitalISSN:- 1573-2568
- Adult
- Anti-Bacterial Agents -- therapeutic use
- Anti-Inflammatory Agents -- therapeutic use
- Antibodies, Monoclonal -- therapeutic use
- Azathioprine -- therapeutic use
- Ciprofloxacin -- therapeutic use
- Crohn Disease -- drug therapy
- Drainage
- Drug Therapy, Combination
- Female
- Follow-Up Studies
- Humans
- Immunosuppressive Agents -- therapeutic use
- Infliximab
- Intestinal Fistula -- drug therapy
- Magnetic Resonance Imaging
- Male
- Methotrexate -- therapeutic use
- Metronidazole -- therapeutic use
- Middle Aged
- Predictive Value of Tests
- Remission Induction
- Retrospective Studies
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.